INTECH Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46M Buy
12,416
+6,107
+97% +$1.87M 0.04% 402
2026
Q1
$1.58M Buy
6,309
+1,061
+20% +$264K 0.02% 795
2025
Q4
$1.44M Sell
5,248
-2,295
-30% -$628K 0.01% 918
2025
Q3
$1.98M Buy
7,543
+3,350
+80% +$814K 0.02% 782
2025
Q2
$917K Sell
4,193
-1,827
-30% -$391K 0.01% 1245
2025
Q1
$1.35M Buy
6,020
+1,307
+28% +$360K 0.01% 1016
2024
Q4
$1.54M Sell
4,713
-1,374
-23% -$432K 0.02% 864
2024
Q3
$1.83M Sell
6,087
-3,235
-35% -$991K 0.02% 515
2024
Q2
$3.07M Sell
9,322
-7,039
-43% -$2.49M 0.04% 352
2024
Q1
$6.47M Sell
16,361
-4,659
-22% -$1.72M 0.09% 188
2023
Q4
$7.4M Buy
21,020
+12,630
+151% +$4.47M 0.11% 189
2023
Q3
$3.15M Buy
8,390
+4,905
+141% +$1.9M 0.05% 294
2023
Q2
$1.33M Sell
3,485
-19,899
-85% -$7.11M 0.01% 416
2023
Q1
$8.1M Sell
23,384
-98,444
-81% -$28.8M 0.07% 311
2022
Q4
$28.7M Sell
121,828
-177,838
-59% -$42.1M 0.22% 130
2022
Q3
$73.7M Sell
299,666
-185,623
-38% -$56.5M 0.55% 35
2022
Q2
$147M Buy
+485,289
New +$158M 0.85% 17

Other funds holding WST

INTECH Investment Management's WST Position: Q2 2026 in Review

INTECH Investment Management increased its West Pharmaceutical (WST) stake by 97% in Q2 2026, buying an estimated $1.87M and bringing the position to 12,416 shares worth $4.46M. The position accounts for 0.04% of the portfolio, ranked #402.

INTECH Investment Management first reported a position in WST in Q2 2022 and has held it in 17 quarters since. The position peaked at $147M in Q2 2022. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • INTECH Investment Management held 12,416 shares of West Pharmaceutical worth $4.46M as of Q2 2026.
  • INTECH Investment Management bought 6,107 West Pharmaceutical shares in Q2 2026, an estimated $1.87M.
  • West Pharmaceutical made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #402 holding.
  • INTECH Investment Management first reported a position in West Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's West Pharmaceutical position peaked at $147M in Q2 2022.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.